Arrêt de service programmé du vendredi 10 juin 16h jusqu’au lundi 13 juin 9h. Pour en savoir plus
Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Stability of a 50 mg/mL Ceftazidime Eye-Drops Formulation

Abstract : Microbial keratitis are severe infections generally linked to risk factors. High-doses antibiotic eye-drops could be required to avoid severe complications. In such cases, hospital pharmacists are in charge of their production given the lack of such formulations on the market. The stability of these antibiotic eye-drops is generally limited to a couple of days and publications generally do not describe addition of microbial preservatives even though it is a European Pharmacopeia requirement. The aim of this study was to describe a new ceftazidime eye-drops formulation at 50 mg/mL with a antimicrobial additive, benzalkonium chloride at 0.04 mg/mL. Physico-chemical studies of this new formulation were performed by a stability indicating HPLC-UV method validated according to ICH standards, osmolality measurements, pH monitoring and visual examinations. Antimicrobial preservative efficacy was evaluated according to the method from the European Pharmacopeia. After 75 days at −20 °C followed by 7 days at 4 °C, or after 7 days at 4 °C, the eye-drops were stable. A degradation trend was finally observed at day 14 at 4 °C A new ceftazidime eye-drops formulation is proposed with a stability of 7 days. Outpatients do not need to return to the hospital pharmacy for repeat dispensing, thus possibly improving treatment compliance.
Type de document :
Article dans une revue
Liste complète des métadonnées
Contributeur : Okina Univ Angers Connectez-vous pour contacter le contributeur
Soumis le : mercredi 8 décembre 2021 - 14:43:59
Dernière modification le : mardi 4 janvier 2022 - 04:04:42
Archivage à long terme le : : mercredi 9 mars 2022 - 18:44:24


Gautier et al 2018.pdf
Fichiers éditeurs autorisés sur une archive ouverte




Eric Gautier, Justine Saillard, Caroline Deshayes, Sandy Vrignaud, Frédéric Lagarce, et al.. Stability of a 50 mg/mL Ceftazidime Eye-Drops Formulation. Pharmaceutical Technology in Hospital Pharmacy, De Gruyter, 2018, 3 (4), pp.219-226. ⟨10.1515/pthp-2018-0025⟩. ⟨hal-02524920⟩



Consultations de la notice


Téléchargements de fichiers